
Sign up to save your podcasts
Or


In this episode, Greg and Rob discuss a recent publication regarding how 340B Program participation may impact the degree of biosimilar utilization. Additionally, the guys recap recent legislative proposals with 340B impact that were advanced by the House Energy & Commerce Committee.
Article citation: Health Affairs 42, NO. 5 (2023): 632–641
By SpendMend Pharmacy5
3232 ratings
In this episode, Greg and Rob discuss a recent publication regarding how 340B Program participation may impact the degree of biosimilar utilization. Additionally, the guys recap recent legislative proposals with 340B impact that were advanced by the House Energy & Commerce Committee.
Article citation: Health Affairs 42, NO. 5 (2023): 632–641

43,687 Listeners

26,012 Listeners

3,680 Listeners

113,121 Listeners

56,944 Listeners

498 Listeners

14,337 Listeners

6,462 Listeners

23 Listeners

15,411 Listeners

3,457 Listeners

8 Listeners

4 Listeners

7 Listeners

0 Listeners